Networking the host immune response in Plasmodium vivax malaria

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Mendonça, Vitor Rr ^a,b   Queiroz, Artur Tl ^a   Lopes, Fabrício M ^c,d   Andrade, Bruno B ^e   Barral Netto, Manoel ^a,b,f  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSIDADE TECNOLÓGICA FEDERAL DO PARANÁ   (Brazil)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f Instituto Nacional de Ciencia e Tecnologia   (Brazil)

Author keywords

Biomarkers; Malaria; Network analysis; Plasmodium vivax

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHEMOKINE; CHEMOKINE RECEPTOR CXCL9; CREATININE; CYTOKINE; HEME OXYGENASE 1; INTERLEUKIN 10; INTERLEUKIN 4; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BRAZIL; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PLASMODIUM VIVAX MALARIA; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; BLOOD CHEMICAL ANALYSIS; BRAZIL; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; MALARIA, VIVAX; MALE; MIDDLE AGED; PLASMODIUM VIVAX; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84874001889     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-69     Document Type: Article

References (41)

1. Biomarkers for susceptibility to infection and disease severity in human malaria. Andrade BB, Barral-Netto M, Mem Inst Oswaldo Cruz 2011 106 70 78 21881759
2. IFN-γ-Producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T Cell accumulation within the brain. Villegas-Mendez A, Greig R, Shaw TN, de Souza JB, Gwyer Findlay E, Stumhofer JS, Hafalla JCR, Blount DG, Hunter CA, Riley EM, Couper KN, J Immunol 2012 189 968 979 10.4049/jimmunol.1200688 22723523
3. IL-10 plays a crucial role for the protection of experimental cerebral malaria by co-infection with non-lethal malaria parasites. Niikura M, Kamiya S, Nakane A, Kita K, Kobayashi F, Int J Parasitol 2010 40 101 108 10.1016/j.ijpara.2009.08.009 19735663
4. An experimental model for fatal malaria due to TNF-alpha-dependent hepatic damage. Seixas E, Oliveira P, Moura Nunes JF, Coutinho A, Parasitology 2008 135 683 690 18377697 (Pubitemid 351733163)
5. Proinflammatory and regulatory cytokines and chemokines in infants with uncomplicated and severe Plasmodium falciparum malaria. Ayimba E, Hegewald J, Ségbéna AY, Gantin RG, Lechner CJ, Agosssou A, Banla M, Soboslay PT, Clin Exp Immunol 2011 166 218 226 10.1111/j.1365-2249.2011.04474.x 21985368
6. Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance. Andrade BB, Reis-Filho A, Souza-Neto SM, Clarêncio J, Camargo LMA, Barral A, Barral-Netto M, Malar J 2010 9 13 10.1186/1475-2875-9-13 20070895
7. Plasma superoxide dismutase-1 as a surrogate marker of vivax malaria severity. Andrade BB, Reis-Filho A, Souza-Neto SM, Raffaele-Netto I, Camargo LMA, Barral A, Barral-Netto M, PLoS Negl Trop Dis 2010 4 650 10.1371/journal.pntd.0000650 20386593
8. Association between the haptoglobin and heme oxygenase 1 genetic profiles and soluble CD163 in susceptibility to and severity of human malaria. Mendonça VRR, Luz NF, Santos NJG, Borges VM, Gonçalves MS, Andrade BB, Barral-Netto M, Infect Immun 2012 80 1445 1454 10.1128/IAI.05933-11 22290142
9. Metabolic adaptation to tissue iron overload confers tolerance to malaria. Gozzelino R, Andrade BB, Larsen R, Luz NF, Vanoaica L, Seixas E, Coutinho A, Cardoso S, Rebelo S, Poli M, Barral-Netto M, Darshan D, Kühn LC, Soares MP, Cell Host Microbe 2012 12 693 704 10.1016/j.chom.2012.10.011 23159058
10. Severe Plasmodium vivax malaria, Brazilian Amazon. Alexandre MA, Ferreira CO, Siqueira AM, Magalhães BL, Mourão MPG, Lacerda MV, GC AMd, Emerg Infect Dis 2010 16 1611 1614 10.3201/eid1610.100685 20875292
11. Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? Lacerda MVG, Fragoso SCP, Alecrim MGC, Alexandre MAA, Magalhães BML, Siqueira AM, Ferreira LCL, Araújo JR, Mourão MPG, Ferrer M, Castillo P, Martin-Jaular L, Fernandez-Becerra C, Del Portillo H, Ordi J, Alonso PL, Bassat Q, Clin Infect Dis 2012 55 67 74 10.1093/cid/cis615 22772803
12. Severe Plasmodium vivax malaria among Sudanese children at New Halfa Hospital. Mahgoub H, Gasim GI, Musa IR, Adam I, Eastern Sudan. Parasit Vectors 2012 5 154 10.1186/1756-3305-5-154
13. Plasmodium vivax malaria admissions and risk of mortality in a tertiary-care children's hospital in North India. Sharma R, Gohain S, Chandra J, Kumar V, Chopra A, Chatterjee S, Aneja S, Dutta AK, Paediatr Int Child Health 2012 32 152 157 10.1179/2046905512Y.0000000012 22824663
14. Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon. Andrade BB, Rocha BC, Reis-Filho A, Camargo LMA, Tadei WP, Moreira LA, Barral A, Barral-Netto M, Malar J 2009 8 121 10.1186/1475-2875-8-121 19500362
15. Towards a precise test for malaria diagnosis in the Brazilian Amazon: comparison among field microscopy, a rapid diagnostic test, nested PCR, and a computational expert system based on artificial neural networks. Andrade BB, Reis-Filho A, Barros AM, Souza-Neto SM, Nogueira LL, Fukutani KF, Camargo EP, Camargo LMA, Barral A, Duarte A, Barral-Netto M, Malar J 2010 9 117 10.1186/1475-2875-9-117 20459613
16. Heme impairs prostaglandin E2 and TGF-beta production by human mononuclear cells via Cu/Zn superoxide dismutase: insight into the pathogenesis of severe malaria. Andrade BB, Araújo-Santos T, Luz NF, Khouri R, Bozza MT, Camargo LMA, Barral A, Borges VM, Barral-Netto M, J Immunol 2010 185 1196 204 10.4049/jimmunol.0904179 20562262
17. Hepatitis B infection is associated with asymptomatic malaria in the Brazilian Amazon. Andrade BB, Santos CJN, Camargo LM, Souza-Neto SM, Reis-Filho A, Clarêncio J, Mendonça VRR, Luz NF, Camargo EP, Barral A, Silva AAM, Barral-Netto M, PLoS One 2011 6 19841 10.1371/journal.pone.0019841 21625634
18. Feature selection environment for genomic applications. Lopes FM, Martins DC, Cesar RM, BMC Bioinformatics 2008 9 451 10.1186/1471-2105-9-451 18945362
19. Disease tolerance as a defense strategy. Medzhitov R, Schneider DS, Soares MP, Science 2012 335 936 41 10.1126/science.1214935 22363001
20. The immune-body cytokine network defines a social architecture of cell interactions. Frankenstein Z, Alon U, Cohen IR, Biol Direct 2006 1 32 10.1186/1745-6150-1-32 17062134 (Pubitemid 46711927)
21. MIG and the regulatory cytokines IL-10 and TGF-β1 correlate with malaria vaccine immunogenicity and efficacy. Dunachie SJ, Berthoud T, Keating SM, Hill AVS, Fletcher HA, PLoS One 2010 5 12557 10.1371/journal.pone.0012557 20838432
22. Elevated levels of IL-10 and G-CSF associated with asymptomatic malaria in pregnant women. Wilson NO, Bythwood T, Solomon W, Jolly P, Yatich N, Jiang Y, Shuaib F, Adjei AA, Anderson W, Stiles JK, Infect Dis Obstet Gynecol 2010 2010 pii:317430 10.1155/2010/317430
23. A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. Othoro C, Lal AA, Nahlen B, Koech D, Orago AS, Udhayakumar V, J Infect Dis 1999 179 279 82 10.1086/314548 9841855 (Pubitemid 29028371)
24. Plasma interleukin-10:Tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications. May J, Lell B, Luty AJ, Meyer CG, Kremsner PG, J Infect Dis 2000 182 1570 3 10.1086/315857 11023485
25. Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Kurtzhals JA, Adabayeri V, Goka BQ, Akanmori BD, Oliver-Commey JO, Nkrumah FK, Behr C, Hviid L, Lancet 1998 351 1768 72 10.1016/S0140-6736(97)09439-7 9635949 (Pubitemid 28269187)
26. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. de Waal MR, Abrams J, Bennett B, Figdor CG, de Vries JE, J Exp Med 1991 174 1209 20 10.1084/jem.174.5.1209 1940799
27. STAT6 is required for the anti-inflammatory activity of interleukin-4 in mouse peritoneal macrophages. Ohmori Y, Hamilton TA, J Biol Chem 1998 273 29202 29209 10.1074/jbc.273.44.29202 9786931 (Pubitemid 28507621)
28. Suppression of RANTES in children with Plasmodium falciparum malaria. Were T, Hittner JB, Ouma C, Otieno RO, Orago ASS, Ong'echa JM, Vulule JM, Keller CC, Perkins DJ, Haematologica 2006 91 1396 1399 17018392 (Pubitemid 44569816)
29. Low levels of RANTES are associated with mortality in children with cerebral malaria. John CC, Opika-Opoka R, Byarugaba J, Idro R, Boivin MJ, J Infect Dis 2006 194 837 845 10.1086/506623 16941352 (Pubitemid 44344133)
30. Naturally acquired hemozoin by monocytes promotes suppression of RANTES in children with malarial anemia through an IL-10-dependent mechanism. Were T, Davenport GC, Yamo EO, Hittner JB, Awandare GA, Otieno MF, Ouma C, Orago ASS, Vulule JM, Ong'echa JM, Perkins DJ, Microbes Infect 2009 11 811 819 10.1016/j.micinf.2009.04.021 19427395
31. Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients. Haicheur N, Escudier B, Dorval T, Negrier S, De Mulder PH, Dupuy JM, Novick D, Guillot T, Wolf S, Pouillart P, Fridman WH, Tartour E, Clin Exp Immunol 2000 119 28 37 10.1046/j.1365-2249.2000.01112.x 10606961 (Pubitemid 30064588)
32. The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. Tannenbaum CS, Tubbs R, Armstrong D, Finke JH, Bukowski RM, Hamilton TA, J Immunol 1998 161 927 932 9670971 (Pubitemid 28323558)
33. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to cerebral malaria in Myanmar. Takeda M, Kikuchi M, Ubalee R, Na-Bangchang K, Ruangweerayut R, Shibahara S, Imai S-i, Hirayama K, Jpn J Infect Dis 2005 58 268 271 16249618 (Pubitemid 41614735)
34. Cu/Zn superoxide dismutase plays important role in immune response. Marikovsky M, Ziv V, Nevo N, Harris-Cerruti C, Mahler O, J Immunol 2003 170 2993 3001 12626552 (Pubitemid 36302172)
35. Oxidative stress in patients with non-complicated malaria. Pabón A, Carmona J, Burgos LC, Blair S, Clin Biochem 2003 36 71 78 10.1016/S0009-9120(02)00423-X 12554064 (Pubitemid 36131097)
36. Low interleukin-12 activity in severe Plasmodium falciparum malaria. Luty AJ, Perkins DJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, Greve B, Matousek P, Herbich K, Schmid D, Weinberg JB, Kremsner PG, Infect Immun 2000 68 3909 15 10.1128/IAI.68.7.3909-3915.2000 10858202 (Pubitemid 30434540)
37. Distinct cytokine profiles define clinical immune response to falciparum malaria in regions of high or low disease transmission. Sinha S, Qidwai T, Kanchan K, Jha GN, Anand P, Pati SS, Mohanty S, Mishra SK, Tyagi PK, Sharma SK, Awasthi S, Venkatesh V, Habib S, Eur Cytokine Netw 2010 21 232 240 21075740
38. Genetic evidence for the aggravation of Plasmodium falciparum malaria by interleukin 4. Cabantous S, Poudiougou B, Oumar AA, Traore A, Barry A, Vitte J, Bongrand P, Marquet S, Doumbo O, Dessein AJ, J Infect Dis 2009 200 1530 1539 10.1086/644600 19835477
39. IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages. Carvalho LH, Sano G-I, Hafalla JCR, Morrot A, de Lafaille MA C, Zavala F, Nat Med 2002 8 166 170 10.1038/nm0202-166 11821901 (Pubitemid 34155128)
40. IL-4 receptor expression on CD8+ T cells is required for the development of protective memory responses against liver stages of malaria parasites. Morrot A, Hafalla JCR, Cockburn IA, Carvalho LH, Zavala F, J Exp Med 2005 202 551 560 10.1084/jem.20042463 16087712 (Pubitemid 41186953)
41. GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Zhu J, Yamane H, Cote-Sierra J, Guo L, Paul WE, Cell Res 2006 16 3 10 10.1038/sj.cr.7310002 16467870 (Pubitemid 43129303)